Obsidian Therapeutics has enrolled the first patient in the registration-enabling [...]
AB2 Bio will receive $30 million from Nippon Shinyaku after [...]
Obsidian Therapeutics has enrolled the first patient in the registration-enabling [...]
AB2 Bio will receive $30 million from Nippon Shinyaku after [...]